Fumihito Ushiyama

This inventor holds 8 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 5 EPO patents. Top assignees: Taisho Pharmaceutical Co., Ltd., Toyama Chemical Co., Ltd.. Active years: 2012-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fumihito Ushiyama. Retrieved from https://idiyas.com/inventor/fumihito-ushiyama

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 (Patent Applications = 2)

CIPO Patents = 2 (Patent Applications = 3)

EPO Patents = 5 (Patent Applications = 7)

Average Co-Inventor Count = 9.3

ph-index = 3

Forward Citations = 16(Granted Patents)

Location History:

Toshima-ku, JP (2013 - 2015)
Tokyo, JP (2012 - 2016)

Company Filing History:

8 out of 314

Taisho Pharmaceutical Co., Ltd.

patents

6 out of 159

Toyama Chemical Co., Ltd.

patents

where one patent can have more than one assignee

Years Active: 2012-2016

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9422240 - Partially saturated nitrogen-containing heterocyclic compound (2016-08-23),

2. 9181229 - Azole derivative (2015-11-10),

3. 9045466 - Amidine compound or salt thereof (2015-06-02),

4. 8524738 - Quinolinones and quinoxalinones as antibacterial composition (2013-09-03),

5. 8367831 - Heterocyclic compound or salt thereof and intermediate thereof (2013-02-05),

6. 8354426 - Naphthyridine derivative monohydrate and method for producing the same (2013-01-15),

7. 8329694 - Quinoxalinones as antibacterial composition (2012-12-11),

8. 8211908 - Heterocyclic compound or salt thereof and intermediate thereof (2012-07-03),

Title: Fumihito Ushiyama: Innovator in Pharmaceutical Compounds

Introduction

Fumihito Ushiyama is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with therapeutic applications. With a total of 8 patents, Ushiyama's work has garnered attention for its innovative approaches to drug development.

Latest Patents

Ushiyama's latest patents include a partially saturated nitrogen-containing heterocyclic compound. This compound exhibits a superior PHD2 inhibitory effect and is represented by a specific general formula. Additionally, he has developed an azole derivative, which consists of novel compounds that bind to FKBP12. These compounds are aimed at providing new therapeutics for the prevention or treatment of alopecia.

Career Highlights

Throughout his career, Ushiyama has worked with prominent companies in the pharmaceutical industry, including Taisho Pharmaceutical Co., Ltd. and Toyama Chemical Co., Ltd. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research.

Collaborations

Ushiyama has collaborated with esteemed colleagues such as Taro Kiyoto and Yasuhiro Tsutsui. These partnerships have facilitated the exchange of ideas and fostered innovation in their respective fields.

Conclusion

Fumihito Ushiyama's contributions to pharmaceutical innovations highlight his role as a leading inventor in the industry. His patents reflect a commitment to advancing therapeutic solutions, making a significant impact on healthcare.

Profile summary based on public USPTO records.